Constrained search

7 methods · 1999–2020

Constrained search: Replace the database with the set of sequences the measurement itself allows. An accurate precursor mass, a determined composition or a known peptide family bounds the candidate set tightly enough to enumerate it outright.

Replace the database with the set of sequences the measurement itself allows. An accurate precursor mass, a determined composition or a known peptide family bounds the candidate set tightly enough to enumerate it outright.

The earliest of its 7 methods is Accurate-mass constrained de novo interpretation (1999); 6 more have followed.

Methods 7
Papers describing them 10
Authors 35
Active 1999-07-01 to 2020-07-01
Kinds algorithm (6), adjacent
Acquisition DDA (7)

Methods (7)

Oldest first, by the paper that describes each one.

  • Accurate-mass constrained de novo interpretation (1999): Uses 10 ppm parent-mass accuracy plus immonium-ion composition to replace the database with the set of sequence permutations the mass allows, then feeds the resulting de novo sequences into a similarity search. An early statement of the hybrid de novo plus homology strategy.
  • Composition-based sequencing (2004): Two-step database-free strategy enabled by FT-ICR mass accuracy: determine the peptide’s amino acid COMPOSITION first, then score only the permutations that composition allows, which is a far smaller search space than conventional de novo sequencing explores.
  • TVNovo (2010): Turns de novo sequencing into a search problem by generating a VIRTUAL database per spectrum, enumerating the candidate sequences the precursor mass allows, then scoring them as a database search would. Built for high-resolution LTQ-FT data.
  • Conovo (2011): Constrained de novo sequencing algorithm for peptide families such as conotoxins.
  • SEQUEST over theoretically complete sequence databases (2015): Enumerates every peptide sequence compatible with the accurate precursor mass and searches them with SEQUEST, turning database search into de novo-like sequencing.
  • Constrained neo-epitope de novo sequencing (2018): Constrained de novo sequencing of MHC-I neoepitope peptides, which differ from a reference peptide by a mutation, from immunopeptidomic MS/MS.
  • PRESnovo (2020): Prescreens neuropeptide precursors for a conserved family motif before de novo sequencing, so only the variable part of the sequence has to be read.

Papers describing them (10)

Authors (35)

Alex DeCourcy, Alma L. Burlingame, Beatrix Ueberheide, Bernhard Spengler, Bingwen Lu, Brian T. Chait, Chang-Ming Xu, Claudia Müller, Dieter Kirsch, Hai-Bin Ma, Haixu Tang, Han-Chang Sun, Hong-Wei Xie, Hui Liu, Ji-Yang Zhang, John R. Yates, John R. Yates III, Karl R. Clauser, Kellen DeLaney, Lemmuel L. Tayo, Lingjun Li, Lourdes J. Cruz, Marshall Bern, Mingming Ma, Peter Baker, Rovshan G. Sadygov, Sujun Li, Swapnil Bhatia, Thomas Flad, Vinh An Thieu, Wei Zhang (Changsha), Weifeng Cao, Yadi Ma, Yong J. Kil, Yuzhuo Zhang

Seen in the charts

Back to the full map

Back to top